Publications show all

Mersana Therapeutics has published 2 articles.

Patents show all

79Applications21Issued

Clinical Trials show all

3Phase 1

SEC Filings show all

D7

Private Funding Events

DateOfferedSoldType
2015-03-03$35,450,006$10,128,576Equity
2014-04-08$14,505,371$14,505,371Equity, Option to Acquire, Security to be Acquired
2012-08-09$26,999,708$12,500,164Equity, Option to Acquire, Security to be Acquired
2012-04-18$10,000,000$10,000,000Debt
2010-02-26$3,500,000$2,500,000Debt
2009-02-23UnknownUnknownOther (Paper Filing)

Key Executives

  • Julie A. Olson
    Executive Officer, Director
  • Peter Leone
    Executive Officer
  • Nicholas G. Bacopoulous
    Director
  • C. Clarke Boyd
    Director
  • Joyce Tsang
    Director
  • Martin Vogelbaum
    Director
  • Thomas Beck
    Director
  • Nicholas G. Bacopoulos
    Executive Officer, Director
  • Michael Metzger
    Executive Officer
  • C. Boyd Clarke
    Director
  • Timothy B. Lowinger
    Executive Officer
  • Burkhard Blank
    Executive Officer
  • Sara Nayeem
    Director
  • David Mott
    Director
  • Karen Hong
    Director
  • Eva Jack
    Executive Officer
  • Donald Bergstrom
    Executive Officer
  • Peter Park
    Executive Officer
  • Wayne Foster
    Executive Officer
  • Anna Protopapas
    Executive Officer
  • Timothy Lowinger
    Executive Officer
  • Elaine Jones
    Director